IP Verse

Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof - EP3293202B2

PatentPatent Analysis

EP3293202

CANTARGIA
Application Number
EP17185792A
Filing Date
Mar 5, 2015
Status
Patent Maintained As Amended
Jan 5, 2024
Grant Date
Feb 7, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3020730B1

Bibliography

The patent EP3293202B2 was granted to Cantargia on Feb 7, 2024 following the initial filing on Mar 5, 2015 under the application number EP17185792A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BLUEFIN BIOMEDICINENov 24, 2021ADMISSIBLE
ICHNOS SCIENCESNov 24, 2021ADMISSIBLE
ZWICKER SCHNAPPAUF & PARTNERNov 24, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents